tradingkey.logo

Oruka Therapeutics Inc

ORKA
32.120USD
+0.410+1.29%
Close 12/24, 13:00ETQuotes delayed by 15 min
1.55BMarket Cap
46.19P/E TTM

Oruka Therapeutics Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-4.99
-12.20%
Analyst Rating
STRONG BUY
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.

What is the Earnings Per Share (EPS) of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -4.987, with a year-on-year change of -12.20%.

What is the net income of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its net income was -83.72M, with a year-on-year change of -1468.16%.

What is the net margin of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.

What is the gross margin of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.

What is the debt-to-asset ratio of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.

What is the Return on Equity (ROE) of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -40.22%, with a year-on-year change of -196.42%.

What is the Return on Assets (ROA) of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -38.59%, with a year-on-year change of -192.56%.

What is the operating profit of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its operating profit was -88.12M, with a year-on-year change of -1107.83%.

What are the current assets of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its current assets were 376.87M, with a year-on-year change of 902.52%.

What are the total assets of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its total assets of Oruka Therapeutics Inc were 396.02M, with a year-on-year change of 945.98%.

What are the total liabilities of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its total liabilities of Oruka Therapeutics Inc were 13.80M, with a year-on-year change of 1540.67%.

What is the total equity of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its total equity of Oruka Therapeutics Inc was 382.22M, with a year-on-year change of 932.47%.

What is the net operating income of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its net operating income of Oruka Therapeutics Inc was -83.72M, with a year-on-year change of -1468.16%.

What is the net investment of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its net investment of Oruka Therapeutics Inc was -330.13M, with a year-on-year change of --.

What is the net financing of Oruka Therapeutics Inc?

According to Oruka Therapeutics Inc's FY2024 earnings report, its net financing of Oruka Therapeutics Inc was 449.54M, with a year-on-year change of --.
KeyAI